Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Interest & Investment Income: 2014-2024

Historic Interest & Investment Income for Iovance Biotherapeutics (IOVA) over the last 9 years, with Dec 2024 value amounting to $20.3 million.

  • Iovance Biotherapeutics' Interest & Investment Income fell 68.96% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 31.31%. This contributed to the annual value of $20.3 million for FY2024, which is 55.43% up from last year.
  • Per Iovance Biotherapeutics' latest filing, its Interest & Investment Income stood at $20.3 million for FY2024, which was up 55.43% from $13.0 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Interest & Investment Income registered a high of $20.3 million during FY2024, and its lowest value of $451,000 during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $13.0 million (2023), whereas its average is $12.1 million.
  • Data for Iovance Biotherapeutics' Interest & Investment Income shows a peak YoY soared of 561.86% (in 2022) over the last 5 years.
  • Over the past 4 years, Iovance Biotherapeutics' Interest & Investment Income (Yearly) stood at $451,000 in 2021, then soared by 561.86% to $3.0 million in 2022, then soared by 336.95% to $13.0 million in 2023, then spiked by 55.43% to $20.3 million in 2024.